In addition, the results in this investigation demonstrate that the levels of FUNDC2 are associated with various immune infiltration levels of B cells, DC, et al. in diverse cancers including BLCA and BRCA (Fig 3), further supporting the specific correlation of the expression of FUNDC2 with the immune infiltration of certain immune cells. The gene discussed is FUNDC2; the disease is cancer.